Traws Pharma, Inc.

Q2 2025 13F Holders

Symbol
TRAW
CUSIP
68232V884
Type
Equity
Class
COM NEW
Num filings
20
Total reported value, excl. options
$1.87 M
Manager Report Date Value ($000) Shares Option Type